We illustrate the speci c cellular distribution of different subtypes of glutamate receptors (GluRs) in peripheral neural and non-neura l tissues. Some of the noteworthy locations are the heart, kidney, lungs, ovary, testis and endocrine cells. In these tissues the GluRs may be important in mediating cardiorespiratory, endocrine and reproductive functions which include hormone regulation, heart rhythm, blood pressure, circulation and reproduction . Since excitotoxicity of excitatory amino acids (EAAs) in the CNS is intimately associated with the GluRs, the toxic effects may be more generalized than initially assumed. Currently there is not enough evidence to suggest the reassessment of the regulated safety levels for these products in food since little is known on how these receptors work in each of these organs. More research is required to assess the extent that these receptors participate in normal functions and/or in the development of diseases and how they mediate the toxic effects of EAAs. Non-neural GluRs may be involved in normal cellular functions such as excitability and cell to cell communication. This is supported by the wide distribution in plants and animals from invertebrates to primates. The important tasks for the future will be to clarify the multiple biological roles of the GluRs in neural and non-neura l tissues and identify the conditions under in which these are up-or down-regulated. Then this could provide new therapeutic strategies to target GluRs outside the CNS.
circumventricular organs that are located outside the blood brain barrier (BBB) (7, 67) . Despite the BBB protective mechanisms, the local or circulating concentrations of these excitatory compounds may induce damage leading to neurotoxic exposure levels. The toxicity of each compound such as domoic acid and Asp varies according to the potency, the chemical availability, the rate of absorption, the af nity to speci c receptors and the particular anatomical target site. In addition, the susceptibility, genetic predisposition and health status of the individual are also important factors.
Domoic acid is one of the most potent neurotoxins that can enter the food chain. It is manufactured by a sea phytoplankton that is ingested and accumulated in the digestive system of seashells such as mussels. Domoic acid was found to be the agent responsible for the outbreak of the lethal shellsh poisoning that occurred in Canada in 1987 (38, 42, 65, 66, 80) . Some of the survivors of this poisoning were left with severe residual memory de cits. Previous work in our laboratory and from others has con rmed that domoic acid preferentially damages areas of the brain involved in memory. The clinical manifestations of domoic acid intoxication are related to its effect in the brain including severe seizures (38, 42, 65, 66, (79) (80) (81) . However, the other clinical symptoms such as: gastrointestinal disturbances, cardiovascular collapse and cardiac arrhythmia (7, 38, 81, 93) have gained less attention, until recently.
In the peripheral tissues, there is also a rich bed of nerve circuits and many cell tissues are also capable of conducting excitatory impulses. This information together with the report of cardiovascular disturbances associated with domoic acid intoxications and other excitatory compounds in foods such as monosodium glutamate (MSG) prompted our initial investigation of the heart as a possible target organ (27-29, 88, 93) . Because it has been established that Glu or its analogues interact with the postsynaptic membrane of glutamate receptors (GluRs) in the CNS, the existence of a similar relationship was explored in other tissues and organs. This review summarizes the current knowledge on the GluRs in peripheral tissues, their distribution, potential role and the effects they can mediate. We hope this review will stimulate research and provide additional information useful in formulating regulatory decisions concerning the public health protection of foods and therapeutic products.
BACKGROUND

Excitatory Amino Acids
Glu and Asp are the most abundant dicarboxylic amino acids in the brain and are believed to be the primary neurotransmitters in the mammalian CNS (20, 21, 62) . Although these amino acids are primarily involved in intermediary metabolism and other non-neuronal functions, their most important role is as neurotransmitters. It is estimated Glu mediates nearly 50% of all the synaptic transmissions in the CNS and its involvement is implicated in nearly all aspects of normal brain function including learning, memory, movement, cognition and development (3, 20, 46-48, 51, 53, 62, 73) . At elevated concentrations, Glu acts as a neurotoxin capable of inducing severe neuronal damage. Hence, Glu can be considered to be a "2-edged sword" that undergoes a transition from a neurotransmitter to a neurotoxin. In addition to the endogenous glutamate, there are naturally occurring substances, which have Glu-like excitatory properties and potentially excitotoxic effects. Glu and its structural analogues ( Figure 1 ) may enter the food supply during preparation or processing as contaminants or additives (9, 42, 65, 66, 69, 79, 81, 86, 88, 93) . These analogues include MSG, L-aspartate, L-cysteine, related sulfur amino acids (ie homocysteate), B-N -oxalyamino-L-alanine (BOAA or ODAP), B-N -methyl-amino-L-alanine (BMAA) and the potent sea food toxin domoic acid (20, 22, 38, 42, 59, 69, 86) . A plethora of ndings in the past 2 decades has provided direct and circumstantial evidence for abnormal glutamate (and its analogues) transmission in the etiology and pathophysiolog y of many neurological and psychiatric disorders such as epilepsy, schizophrenia, addiction, depression, anxiety, Alzheimer's, Huntington's, Parkinson's and amyotrophic lateral sclerosis (3, 20, 21, 24, 25, 36, (46) (47) (48) 51) .
The neurotoxic effects of the EAAs are dependent on the species, developmental stage of the animal, type of agonist, duration of exposure to the agonist and the cellular expression of the GluR subtypes. An array of GluRs are known to be present on pre-and postsynaptic membranes that are used to transduce integrated signals using an increased ion ux and second messenger pathways ( Figure 2 ) (16, 17, 20, 25, 36, 62, 73) . It is the excessive activation of these receptors that leads to neurotoxicity. 
Glutamate Receptors: An Overview
Numerous reviews are available on the GluRs in the CNS, their functional roles and implications on the pathobiology of neural injury and neuropsychiatric disorders (3, 20, 21, 24, 36, 48, 53, 62, 73) . GluRs have been individually characterized by their sensitivity to speci c glutamate analogues and by the features of the glutamate-elicited current. GluR agonists and antagonists are structurally similar to Glu, which allows them to bind onto the same receptors.
Two classes of GluRs have been characterized based on the studies in the CNS: ionotropic (iGluRs) and metabotropic (mGluRs). Their cloning has revealed the molecular diversity of the gene families encoding various receptor types that are responsible for the pharmacological and functional heterogeneity in the brain. A brief resume is outlined in the present study because comprehensive treatment of these GluRs has been previously reviewed in detail (3, 16, 17, 20, 25, 36, 53, 62, 74) .
Ionotropic Glutamate Receptors
The iGluRs contain integral cationic channels associated with ligand binding sites and they are known to mediate rapid synaptic transmission. The iGluR family is classi ed into 3 major subtypes according to their sequence similarities, their electrophysiological properties and their af nity to selective agonists: N -methyl-D-aspartate (NMDA), a -amino-3hydroxy-5-methyl-4-isoxazol e propionic acid (AMPA) and TOXICOLOGIC PATHOLOGY FIGURE 2.-Schematic representation of the interaction betweeen the presynaptic and the postsynapti c terminal. The gure shows vesicular release into the synaptic space, activation of the postsynapti c receptor systems, reuptake into the presynaptic terminal and surrounding glial cells. The excitatory amino acids (for example glutamate) activates the various glutamate receptors present in the postsynapti c membrane. This triggers the in ux of Ca 2 from the extracellular environmen t to the synaptic cleft. The accumulation of Ca 2 is crucial determinant of injury. This elevation of Ca 2 triggers the activation of several enzymes: calmodulin (CAM), protein kinase C (PKC), nitric oxide synthase (NO synthase), phospholipas e A 2 (PLA2) and reactive oxygen species (ROS)-modi ed from Harry (33) and Said (1999) . kainate (Ka) receptors (3, 20, 21, 36) . The membrane channels associated with these receptors exhibit varied pharmacological and electrophysiological properties, including ionic channel selectivity to sodium (Na ), potassium (K ) and calcium (Ca 2 ) (3, 20, 21, 36, 62). The non-NMDA receptors control a nonselective cationic channel permeable to Na and K , whereas NMDA is more permeable to Ca 2 ions than either AMPA or Ka (3, 20, 21, 36, 62) . Recombinant technology has identi ed several gene families encoding iGluRs: AMPA family is composed of GluR 1-4 (GluR A-D); Ka family includes GluR 5-7 and Ka 1-2; NMDA includes NMDAR 1 and NMDAR 2A-D. NMDAR 1 is the most tightly regulated neurotransmitter receptor by forming the channel where other subunits (NMDA 2A-D) are involved in the receptor modulation. It is the most intensively studied and complex receptor and is linked to the Na /Ca 2 ion channel that has 5 distinct binding sites for endogenous ligands that in uence its opening (20, 21, 36, 62) . These include 2 different agonist recognition sites (1 for Glu and 1 for glycine), a polyamine regulatory site that promotes receptor activation. The remaining sites separate recognition sites for Mg 2 , Zn 2 and phencyclidine (PCP), which inhibit ion ux through agonistbound receptors (20, 21, 36, 62) . The complexity of these GluR families is further increased by alternate splicing, RNA editing and post-translational modi cations such as phosphorylation, glycosylation and palmitoylation. Each of these modi cations is important in the regulation of channel functions. Within each family, GluRs subunits can also form homo-oligomeric or heteroligomeric channels that exhibit different functional properties depending on the subunit composition. For example, the presence of the GluR 2 subunit decreases Ca 2 permeability of AMPA channels (20, 21, 36, 62) .
Metabotropic Glutamate Receptors
The mGluRs exert their effects either on the second messengers or ion channels via the activation of the of GTPbinding proteins and regulate the synthesis of different intracellular second messengers such as IP 3 , cAMP or cGMP (17, 21, 36, 62, 73) . A single mGluR protein can cross-talk with multiple second messengers in the same cell. As with iGluRs, the mGluRs are also classi ed into 4 groups based on amino acid sequence similarities, agonist pharmacology and the signal transduction pathways to which they are coupled. Group I (mGluR 1, 5, and 6) stimulates inositol phosphate metabolism and mobilization of intracellular Ca 2 . Group II (mGluR 2 and 3) and group III (mGLuR 4, 6-8) are coupled to adenyl cyclase (17, 21, 36, 62, 73) . Group IV is coupled to to the activation of phospholipase D (PLD). The latter class is more ef ciently activated by L-cysteine-sul nic acid (L-CSA) rather than Glu, which suggests that L-CSA may serve as an endogenous agonist of this receptor (16) . The mGluRs function is predominantly with the long-term aspects of cellular control by operating via G proteins and several second messenger systems. As with the iGluRs, the mGluRs also have a unique distribution in the CNS and retina, which re ects a diversity of function in normal and pathological processes. These receptors have been shown to exert a wide variety of modulating effects on both excitatory and inhibitory synaptic transmission. This is expected if a receptor activation is coupled to multiple effector enzyme (17, 21, 36, 62, 73) .
The mGluRs have certain features that distinguish them from the iGluRs. First, the mGluRs modulate the activity of neurons rather than mediate fast synaptic neurotransmission. Second, the distribution of the mGluRs is highly diverse and heterogenous. Different subclasses are localized uniquely at both the anatomical and cellular levels. For example, mGluR 2 and 3 are found in high density in the cerebral cortex, whereas mGluR 4 is found in high density in the thalamus but not in the cortex and mGluR 6 is almost exclusively found in the retina.
GLUTAMATE RECEPTORS IN PERIPHERAL TISSUES Introduction
A recent surge of publications supports the presence and functionality of GluRs outside the CNS in various tissues and species. Table 1 summarizes the distribution of the GluRs in peripheral tissues demonstrated by using various methodologies such as: RT-PCR, PCR, northern blots, western blots, immunohistochemistry and in situ hybridization. These tissues include adrenal medulla (85, 90) , peripheral nervesmyelinated and unmyelinated (1, 15) , bone (14, 26) , bone marrow (26), bronchial smooth muscle, endocrine pancreas (4-6, 30, 32, 37, 45, 49, 54, 87), gut (8, 58, 77, 81, 86) , esophagus (this study), hepatocytes (27, 78) , heart (27, 28, 55, 69, 87) , taste buds (12, 35) , keratinocytes (55), lungs (29, 34, 70, 77) , pituitary (41, 86) , pineal gland (52), ileal longitudinal muscle (56, 74, 75) , autonomic and sensory ganglia (85), rat glaborous skin (10), kidney, spleens, ovaries, (26, 28, this study), vagus and other cholinergic nerves (1), tachykinincontaining sensory nerves and vestibular tissues (18) . In our studies, we have conducted a thorough analysis on the distribution of the GluRs in peripheral tissues of the rat where the antibodies and the methodology used have been previously described (27, 28, 29) . Different subtypes of GluRs were observed in the heart, spleen, testis and kidney (27, 28, 29) . These ndings and that of others clearly supports the view that GluRs are widely present in peripheral tissues and have a speci c cellular distribution.
Some of the GluRs isolated from peripheral tissues have been cloned and sequenced (10, 12, 14, 24, 27, 32, 36, 87) . These sequences correspond with GluRs that have been cloned in the CNS. Further physiological and pharmacological experiments support the hypothesis that GluR receptors in the periphery have similar properties to those in the CNS or expressed in host cells transfected with cloned subunits (28, 30, 36, 56, 71, 74, 84, 87) . For example, the AMPA receptors in the rat pancreas respond to L-glutamate, AMPA and kainate. These receptors were blocked by competitive antagonists, 6-cyano-7-nitroquinoxalin e (CNQX) and potentiated by cyclothiazide (87) . These properties are also shared by neuronal AMPA receptors. In addition, the stimulation of cultured rat myocardial cells by L-glutamate leads to an increase in the intracellular Ca 2 oscillation frequency (88) . Similar physiological studies with agonists and antagonists of the NMDAR 1 receptor in the pig ileum have shown that these receptors are similar to those characterized in the CNS (73) . NMDAR 1 receptors in the pig ileum were also blocked by Mg 2 ions and competitively antagonized by DL-2-amino-5-phosphonovaleri c acid.
Glutamate Receptors in the Heart and Cardiac Arrhythmia
We have extensively investigated the presence of the GluRs in the rat (27, 28) . The preferential localization of GluRs was seen within the conducting system, nerve terminals and intramural ganglia cells ( Figure 3 ). Similar distribution, but with enhanced de nition was observed in the conducting systems in the monkey heart (in preparation, 57). These ndings likely re ect the higher level of anatomical differentiation of the conducting system in nonhuman primates versus the rodents as illustrated by using the neural markers PGP 9.5 and NF (57) . The presence of the GluRs in areas speci cally involved in the conduction of impulses suggests their involvement in the control of heart rhythm. Therefore, the presence of the GluRs in the heart implies that this organ may be an important target site for compounds such as domoic acid, which is a known ligand for these receptors.
The presence of GluR in the intramural ganglia cells and cardiac nerve bers, which are known to be components of the peripheral autonomic nervous system, prompted us to investigate the presence of GluRs in other tissues.
Glutamate Receptors in Kidney and Electrolyte-Water Homeostasis
In the kidney, the wide distribution of NMDAR 1 and the presence of mGluR 2/3 and GluR 2/3 in the juxtaglomerular apparatus (JGA) and proximal tubules (Figures 4a, b , c, and d), suggests that these receptors may be involved in electrolytes and water homeostasis. The strong visualization of immunoreactivity with anti-mGluR 2/3 and anti-GluR 2/3 within the granular cells of the afferent arteriole suggests a potential involvement in the control of renin release (18, Figures  4b and c) . The renin-angiotensin system is a major hormonal system involved in the regulation of electrolyte, uid balance and blood pressure (39) . Pharmacological and biochem-ical evidence also supports the presence of the dopamine receptors-D 1A , D 1B , D 2 , and D 3 within the kidney (58, 72, 94) . Like the GluRs, the dopamine receptors were also specifically distributed. D 1A and D 1B are both reported to be present in the renal vasculature, renal proximal and distal convoluted tubules, cortical and collecting ducts. In contrast, D 1A is not present in JGA apparatus and the ascending loop of Henle, whereas D 1B is present in these regions. Experimental data suggests that dopamine receptors are involved in renal hemodynamics, ion transport and renin secretion (58, 72, 94) . In addition to the GluRs and the dopamine receptors, the GABA receptors are also found in the kidney. The GABA A and GABA B receptors have been localized to the renal cortex (11) . Therefore, GABA might also in uence the renal functions in the kidney cortex rather than the medulla. Whether or not there is co-localization or co-functionality of these receptors needs to be determined.
Glutamate Receptors in Sex Organs and Reproduction
We have shown the differential distribution of GluRs in reproductive organs of the male (Figures 4e-i) and female rat ( Figures 5 and 6 ). In the testis, these receptors have a speci c af nity for different structures. There is intense anti-mGluR 2/3 immunolabelling of the head of the mature spermatids/spermatozoa, interstitial cells and myoid cells. Anti-NMDAR 1 has a strong af nity for the germinal epithelium, particularly the spermatogonia adjacent to the basal lamina and the more mature spermatids near the lumen (Figure 4e ), whereas the anti-GluR 2/3 immunostain is limited to the cells in the interstitial spaces. This differential distribution suggests that GluRs may be involved in spermatogenesis, spermatozoa motility and testicular development-each linked to a speci c receptor. To support our hypothesis, we are investigating the presence and distribution of GluRs in rat testes during various developmental stages. Previously, it has been shown that speci c binding sites for [ 3 H]-TCP, a ligand that labels a binding site within the NMDA receptor ion channel, has been demonstrated on membranes of mammalian spermatozoa. Morever Cl -independent [ 3 H]glutamate binding, which could be partially displaced by NMDA and AP5, has also been detected in seminal vesicles (20) . Further, the results of Lara and Bastos-Ramos (44) suggest the noradrenergic neurons innervating the rat vas deferens are controlled by a glutamate-dependent excitatory process in the ganglia. They showed that a single dose of kainate to the ganglia induced a decrease in the norepinephrine content of the vas deferens. Binding studies using [ 3 H]-glutamate to the membrane fraction showed that the binding was saturable. This binding was inhibited by different analogues according to different potencies L-glutamate > kainate > quisqualate N -methyl-D-aspartate. Thus, it is likely that the vas deferens has a glutamatergic excitatory mechanism for the control of their activity and these are responsible for the depolarizing potential on the noradrenergic neurons. This mechanism might be important for the contractile activity of the vas deferens and hence in the control of seminal uid (44) .
In the rat female reproductive system, GluRs also have a unique distribution within each organ ( Figures 5 and 6) . Each antibody has a differential af nity to speci c structures in the ovaries, the fallopian tubes, the cervix, the myometrium and the endometrium (Figures 5 and 6 ). In the ovary ( Figure 6 ) FIGURE 4 .-Photomicrographs of the rat kidney and testis perfused with 4% PFA and processed for immunohistochemistr y. Microwaved paraf n sections were immunostained with speci c antibodies to GluRs, using LAB/avidin biotin method and DAB as chromogen. A) Immunostainin g with anti-NMDAR 1 is seen in the distal tubule, proximal tubule, and glomeruli, particularly in the mesangium and podocytes (shown by an arrow). B) Anti-mGluR 2/3 strong immunostain in the convoluted proximal tubules and the JGA (arrow). C) Higher magni cation of the JGA, showing anti-mGluR 2/3 dark cytoplasmic staining of the granular cells in the wall of the afferent arteriole. D) Anti-GluR 2/3 stain distribution is similar to the anti-mGluR 2/3. E) Anti-NMDAR 1 strong af nity for the germinal epithelium, particularly the spermatogoni a adjacent to the basal lamina and the more mature spermatids near the lumen. F) & G) Anti-GluR 2/3 immunostai n is limited to the interstitial spaces. H) Intense anti-mGluR2/3 immunolabelling of the head of the mature spermatids/spermatozoa , and I) Interstitial and myoid cells. Abbreviations: afferent arteriole (AA); distal convoluted tubule (D); proximal convoluted tubule (PT); mesangium (M); glomeruli (G); juxtaglomerular apparatus (JGA); interstitial spaces (IS); seminiferus tubules (ST); spermatogonium (SP); spermatids (SP) (29).
FPO
FIGURE 5.-Immunohistochemica l analysis of various subtypes of GluRs. Paraf n sections of rat uterus xed with 4% PFA, immunostained using the LAB/avidin biotin method and DAB as chromogen. Each subtype of GluR Abs tested has a differential speci c distribution. Anti-mGluR shows preferential binding to the most super cial layer of the strati ed squamous epithelium of the exocervix (A), whereas the full thickness of the epithelium is stained with anti-NMDAR 1 (C) and remains unstained with anti-GluR 2/3 (E). Cross-section of the body of the uterus stained with H&E, depicting the myometrium and endometrial glands (B). Endometrial glands show moderate staining with anti-NMDAR 1 (F). Anti-Glu R 2/3 has strong af nity for the endometrial glands, myometrium (D) and the ciliated epithelium of the fallopian tube (G, H). Abbreviations: exocervica l epithelium (CE); myometrium (M); endometrial glands (EG); stroma (S); fallopian tube or oviduct (FT); lumen (L); ciliated epithelium (this study). FPO FIGURE 6.-Rat ovaries xed in 4% PFA and stained with H&E (A). Microwaved paraf n sections were immunostained with speci c antibodies to various subtypes of GluRs, using the LAB/avidin biotin method and DAB as chromogen . Immunostain with anti-GluR 2/3 shows a wide distribution throughout the ovary, including stroma; corpus luteum; and within the follicles, the granular cells, theca, and oocytes (B, C, D). The intensity of the stain varies and is higher within the more mature follicles, oocytes, and corpus luteum. Anti-mGluR 2/3 also shows af nity for the corpus luteum and oocytes (E, F), but is very faint for other structures. Anti-NMDAR 1 has strong selective af nity for the oocyte (G). Nerve ber within the suspensory ligament stained with all the antibodies, anti-GluR 2/3 (H). Abbreviations: ovary (OV); follicles (FL); oocyte (Oc); granulosa cells (Gc); theca (T); corpus luteum (CL); nerve bers (NF) (this work). the distribution of GluRs within the follicles varies at different stages of their maturation. In the rat anti-NMDAR 1 and to some extent anti-GluR 2/3 and anti-mGluR 2/3, have a remarkable selective af nity for the oocyte. GluR 2/3 and mGluR 2/3, but not NMDAR 1 are visualized in the corpus luteum. In the uterus ( Figure 5 ), anti-GluR 2/3 showed strong af nity for the ciliated epithelium of the fallopian tubes, smooth muscle of the myometrium and endometrial glands, whereas anti-NMDAR 1 is more selective to the endometrial glands and the exocervical epithelium. This suggests that these receptors may be involved in ovulation, fertilization, implantation of the ovum and excitability of the uterus. To examine if similar preferential distributions exist in higher mammals, we have tested the location of GluRs in the sex organs of nonhuman primates, using ovary, uterus and fallopian tubes of Macaca fascicularis. In this species, the corpus luteum and oocytes display intense, selective immunolabelling with anti-NMDAR 1 and anti-GluR 2/3 (manuscript in preparation).
The presence of the GluRs within the reproductive organs and the known functional inhibitory/excitatory effects of GABA/GABA receptors (22) suggest that similar excitatoryinhibitory neurotransmission interplay may also be present in the reproductive organs using GluRs as mediators. Therefore reproductive functions-such as gonadal maturation; steroidal sex hormone regulation; maturation, motility, and excitability of the spermatozoa; ovulation; fertilization; excitability of the fallopian tubes; implantation of the ovum; and excitability of the myometrium-may be all affected. This warrants testing as it has important therapeutic and toxicological implications.
Glutamate Receptors in Neuroendocrine Tissues and Hormone Secretion
In addition to the gonads, we and other researchers (5, 6, 37, 41, 49, 53, 54, 84, 85, 87, 91) have shown the presence of GluRs in other endocrine tissues. These include the pancreas, pituitary, pineal gland, adrenal gland and kidney. The differential distribution of the GluR subunits in the pancreas has already been described (37, 54, 87) . Liu et al (49) showed that GluR 1 and GluR 4 were mainly localized to insulin-secreting cells in the central mass of the pancreatic islet, whereas GluR 2/3 was preferentially localized in the peripheral rim composed of non-insulin-secreting islet cells. It appears that insulin-and non-insulin-secreting cells express different AMPA receptor subunits, which may be used to mediate their hormone secretion, as was suggested earlier by Bertrand (5, 6) . Weaver et al (87) showed that the AMPA receptors were located in the a , b , and PP cells but were generally absent from the c cells, whereas kainate receptors were expressed in the a and c cells although they were not found in b or PP cells. These observations add to the evidence that these receptors may be involved in the regulation of hormone secretion (4-6, 37, 86). Studies of Weaver et al (87) show that Glu depolarizes islet cells when Glu serum levels are elevated. Intracellular Ca 2 measurements and electrophysiologica l recordings showed that kainate, AMPA and NMDA elicited increases in Ca 2 in single b -pancreatic cells and depolarized them. In addition, kainate and AMPA stimulated the release of insulin whereas NMDA did not (36) . This stimulatory effect was dependent on the glucose con-centration: Glu stimulated insulin release in the presence of a glucose concentration of 8.3 mM but not in the presence of a low concentration (2.8 mM). Hence, Glu is a potentiator of glucose-induced insulin release. In addition to the GluRs, the presence of GABA receptors has also been reported in the pancreas (11, 76, 86) . Therefore, the nal activity of these cells is probably determined by the balance in the activities of both GluR and GABA receptors. It is therefore conceivable that these receptors are involved in the pathophysiolog y of the pancreas.
Glutamate Receptors in the Gastro-Intestinal (GI) Tract
Experimental evidence from several labs and from this laboratory (Figure 7 ) have shown the GluRs to be present in the stomach, duodenum and descending colon (8, 56, 74, 75, 83) . Immunohistochemical analysis showed that GluRs antibodies had poor af nity for the esophagus with the exception of anti-NMDAR 1, which preferentially stained the less mature cells within the basal layer of the strati ed squamous epithelium (Figure 7 ). In the stomach mucosa, parietal cells were stained with anti-GluR 2/3, anti-NMDAR 1 and anti-mGluR 2/3. Mast cells throughout the GI tract show strong staining with anti-NMDAR 1. All the antibodies showed some af nity for enteroendocrine cells, ganglia cells and nerve bers throughout the GI tract. Our ndings with the NMDAR 1 are similar to those described by Burns et al (8) . We show the presence of NMDAR 1 expression in the stomach, duodenum, ileum and descending colon. Previous studies have shown that Glu, through the action of NMDAR 1, induces contraction of the ileal longitudinal smooth muscle/myenteric plexus (74) . The myenteric plexus is a layer of neurons innervating the gastrointestinal tract, which is largely responsible for gastrointestinal motility. The role of NMDA receptors in intestinal motility was con rmed by the capability of Glu, Asp, L-homocysteate and NMDA (but not kainate or quisqualate) to cause muscle contraction. The contraction was blocked by NMDA antagonists (noncompetitively by Mg 2 and by phencyclidine-like drugs such as etoxadrol, dextromethorphan, and MK801) but not by kainate or quisqualate antagonists. The order of potencies for the contractile effects is: L-glutamate > aspartate > L-homocysteate > NMDA > Dglutamate (73) . In the CNS, electrophysiological L-glutamate and L-aspartate are less potent than NMDA due to their avid uptake. The results of Shannon and Sawyer (74) suggest an absence of the uptake processes of these compounds in the myenteric plexus. These results are in agreement with Moroni et al (56) .
The studies of Tsai et al (82, 83) showed that Glu and Asp are both involved in regulating acid secretion in the stomach. However, their mode of action is different. They found that Asp was more speci c than Glu in regulating acid secretion. This was attributed to the fact that Glu is a general agonist for all types of GluRs, yet Asp is a potent agonist for NMDAR receptors.
Glutamate Receptors in Other Tissues
Patton et al (64) showed the presence of different GluRs subunits-GluR 2/3, NMDAR 1, mGluR 2, 4, 5, and 7 in bone. Further, using the agonists MK801 and AP5, they demonstrated that bone cells have the potential to express many of the molecules associated with the glutamate-mediated FPO FIGURE 7.-Photographs show the immunohistochemica l localization of GluRs within the gastro-entero-pancreati c system. Microwaved paraf n sections immunostained using the LAB/avidin biotin method and DAB as chromogen . Each subtype of GluRs Ab tested has a speci c distribution. A & B) Anti-GluR 2/3 immunostaining of the af nity for the parietal cells (PC) and the endocrine cells (EC) of the stomach mucosa. C) Anti-NMDAR 1 staining of the ganglion cells (GC) and the EC cells of the bowel. All the Abs showed some af nity for GC and NF throughou t the tract. D) Pancreatic islets stained with anti-GluR 2/3. The intensity of the stain varied with the subtype GluR 2/3 > mGluR 2/3 > NMDAR 1. None of the Abs stained with the exocrine pancreas. Anti-GluR 2/3, but not the other Abs, stained the wall of the blood vessels in the pancreas (D). Abbreviations: parietal cells (PC) of the stomach; enteroendocrin e cells (EC); ganglion cells (GC); goblet cells (G). signalling. Chenu et al (14) documented that all mature cell types (osteoblasts, osteocytes, and osteoclasts) express one or more of the GluRs subunits. The blockade of NMDA receptors with antagonists resulted in inhibition of osteoblast formation, suggesting that NMDAR 1 are functional in bone. In particular, NMDAR 1 was most abundant on bone cells. Glutamate/aspartate transporter (GLAST) has also been identi ed in bone (14) , further supporting the view that neuroexcitatory amino acids may play a role in paracrine signalling in bone cells. The GLAST performs an essential function during glutamate-mediated synaptic neurotransmission by acting as a high af nity uptake system to remove released Glu from the synaptic cleft, thus preventing overstimulation of the postsynaptic glutamate receptors. Thus, the presence of GLAST in the bone and other tissues supports the theory that Glu signalling may have a role outside the CNS.
More recently, the presence of the glutamate receptors NMDAR 1 and NMDAR 2 were demonstrated in bone mar-row of the rat, human megakaryocyte and the MEG-01 clonal megakaryoblastic cell line (see Table 1 ). An interesting observation is that the level of glycosylation in these cells is reduced or absent as compared to the CNS-NMDA type. It is speculated that glycosylation provides stability to the NMDA receptor in the synaptic membrane for the precise orientation and localization in the CNS. However, in the megakaryocyte, the receptors are distributed evenly across the cell surface, which allows for multidirectional agonist stimulation. These receptors are probably involved in signalling, which is reinforced by the ndings that megakaryocyte exist in intimate contact with cells bearing the glutamate-transported proteins GLT-1 and GLAST, which are found on mononuclear bone marrow cells and osteoblasts, respectively. These transporters are essential requirements for functional glutamate-mediated communications. Genever et al (26) showed that NMDAR 1 activity was necessary for phorbol myristate acetate (PMA)induced differentiation of megakaryoblastic cells; NMDAR 1 receptor cell blockade by speci c antagonists, MK-801 or D-AP5; inhibited PMA-mediated increases in cell size; CD41 expression; and adhesion of MEG-01 cells.
Several mGluRs-mGluR 1, 2, 3, and 5-were also reported in the thymic stromal cell line (TC1S) and in the thymocytes. Using RT-PCR and western blotting, it was demonstrated that the thymic stromal cell line TC1S expressed mGluR 2, 3, and 5. Thymocytes expressed mGluR 1, 3, and 5. Fluorescence Activated Cell Sorter (FACS) analysis illustrated that majority of the unfractionated thymocytes (70%) showed the presence of mGluR 5, whereas 50% of the cells expressed mGluR 3 and only 15% expressed mGluR 1. In contrast, isolated CD4 /CD8 , double negative thymocyte precursor, expressed mGluR 3 (45%) and mGluR 1 (40%), whereas mGLuR 5 was barely detectable. Therefore, it was hypothesized that changes in mGluRs subtype expressions may be related to T-cell maturation stages (31) . GluRs are also expressed in other lymphoid tissues and in ammatory in ltrates ( Table 1) .
The iGluRs (27) and mGluRs (77) were also present in the liver. Sureda et al (77) showed mGluR 5 in the primary hepatocytes stimulated the hydrolysis of inositol phospholipid. The effects of mGluRs agonists, 1S,3R-ACPD and quisqualate, was examined on anoxia-induced cell damage. A time-dependent decline was observed on the viability and was maximal after 90 minutes. Both 1S,3R-ACPD and quisqualate shortened this time course of anoxia-induced cell damage, reducing signi cantly the viability of primary hepatocytes. In contrast, the agonist 4C3HPG for the type 11 mGluR had no effect. The hypothesis is that this receptor is activated by the Glu present in the portal blood and may contribute to the liver damage under adverse conditions.
Glutamate Receptors as Possible Mediators of Cell and Tissue Injury and Pathology
The view that Glu or related excitatory amino acids can cause neuronal injury as a result of overexcitation is called excitotoxicity. The GluRs are known to act as mediators of in ammation and cellular injury through a common injury pathway (46, 47, 48, 51 ; see Figure 2 ). In the CNS, the stimulation of GluRs triggers an excessive in ux of calcium into neurons through the ion channels, which mediates neural injury (13, 20, 21, 22, 46, 47, 48, 52) . Because the iGluRs are ion-gated channels selective to Na , K , and Ca 2 , any sustained stimulation of the GluRs results in osmotic damage due to the entry of excessive ions and water. This increases the intracellular Ca 2 concentration which is crucial to the determinant of injury. It is this high concentration of Ca 2 that triggers the activation of several enzyme pathways and signalling cascades including as phospholipases , protein kinase C, proteases, protein phosphatases, nitric acid synthases and the generation of free radicals (3-13, 19, 20, 46, 48, 51) . The destabilization of Ca 2 homeostasis also causes the translocation of protein kinase C (PKC) from the cytoplasm to the membrane. This leads to the phosphorylation of the membrane proteins via PKC promoting the destabilization of the regulatory mechanisms for Ca 2 homeostasis, which mediates toxicity (13, 20, 21) . On activation of phospholipase A 2 , arachidonic acid (with its metabolites and platelet-activating factors) is generated. Platelet-activating factors increase the neuronal calcium levels by stimulating the release of Glu. Arachidonic acid potentiates NMDA evoked currents and inhibits the reabsorption of Glu into astrocytes and neurons. This further exacerbates the situation by a positive feedback mechanism where free radicals are formed during arachidonic acid metabolism, leading to further phospholipase A 2 activation. This results in an increased concentration of extracellular glutamates which contributes to the sustained activation of the GluRs (13, 16, 20, 21) . As a consequence, cysteine transport is inhibited causing a decrease of intracellular reducing sulphydryls and the generation of oxygen radicals, which results in cell death. In addition to enzymes of the cell cytosol, the nuclear enzymes are also activated by increase of Ca 2 . For example, Ca 2 may activate endonucleases that result in condensation of nuclear chromatin and eventually DNA fragmentation and nuclear breakdown, a pathologic process known as apoptosis. Free radicals also contribute to DNA fragmentation.
The increased concentration of Ca 2 raises the nitric oxide via the calmodulin activation of nitric oxide synthetases, which generates oxygen radicals. Nitric oxide has been observed in peripheral tissues, ganglion cells, nerve bers, cardiocytes, and myocytes in the heart of pig and rat. Our work has demonstrated the presence of the glutamate receptors in the same structures. Liu et al (49) showed the colocalization of nitric oxide and AMPA receptors in ganglion cells of the pancreas. Because the nitric oxide is calcium-and calmodulindependent and the AMPA receptors are Ca 2 permeable, it is possible that nitric oxide is activated through the AMPA receptors. We propose that the mechanism involved in injury in the CNS may be a basic mechanism for injury in all tissues. This is supported by the nding that excessive activation of the NMDAR 1 in the lungs induces acute edema and lung injury as seen in "adult respiratory distress syndrome" (70, 71) . This injury can further be modulated by blockage of one of three critical steps: NMDA 1 binding, inhibition of NO synthesis, or activation of poly (ADP-ribose) polymerase (70, 71) . Our results showed immunolabelling for various GluRs in bronchial epithelium, blood vessels of the lungs, mast cells, and in ammatory cells. This supports the view that they play a role in airway responses to injury and in ammation. All the antibodies tested for the subtypes of GluRs showed af nity to mast cells in all tissues analyzed, particularly in the lungs and gastrointestinal tract. Their presence in the airway structures such as the larynx, esophagus and mast cells also implicate the GluRs in the mediation of asthmatic episodes (2, 70, 71) . The excitation of GluRs in the air passages therefore may be important in airway in ammation and hyperreactivity observed in bronchial asthma (60) . Their presence also could explain the enhancement of acute asthmatic attacks by glutamate-containing foods (2) . These researchers did blind placebo-controlled experiments where subjects with asthma received MSG in tablet form. Their studies showed that MSG did indeed provoke asthma, which in some cases was severe and life-threatening.
Mast cells are known to be found in the connective tissues throughout the body, most abundantly in the submucosa tissues and the dermis. Purcell et al (68) showed that spermidine-induced release from the mast cells are dependent on the presence of Ca 2 in the external mileau. The in ux of Ca 2 is known to be accompanied by NMDAR 1 activation. This increased intracellular Ca 2 concentration initiates the exocytotic degranulation process in mast cells. Spermine is a natural polyamine, and the opening of the ion channel associated with NMDAR receptors is facilitated by binding sites for polyamines. In neuronal tissue, polyamine triggers histamine secretion through interaction with a polyamine site associated with an NMDAR 1 macrocomplex. Therefore, spermine can modulate activation of the macrocomplex, either through action at polyamine-binding sites in the lung or at other sites. The antagonists of NMDAR 1, MK801, blocked this release of histamine secretion that was induced by the natural polyamine-spermine. If the NMDAR 1 is present, as supported by (68, 70, 71) , then it opens up the possibility that EAAs can also in uence allergic reactions.
Glu and related EAA agonists induce neurotoxic damage in the CNS, which occurs under conditions of hypoxia or ischemia and is believed to be due to the increased intracellular Ca 2 concentration (13, 20, 21, 25, 36, 48) . Intestinal mucosa damage has also been reported after hypoxia and ischemia (61) .
CONSIDERATIONS ON THE PHYLOGENY
OF GLUTAMATE RECEPTORS Recent data suggests that putative iGluRs exist in plants, in both monocotyledons and dicotyledons. These observations are based on northern and heterologous Southern blot analysis (43) . Preliminary data indicates that the GluRs are involved in light signal transduction. Therefore, it is possible that signalling between cells by EAAs may have evolved from primitive mechanisms before the divergence of plants and animals. GluRs and other similar signalling systems are actually ancestral methods of communication, common to plants and animals alike. This is supported by the fact that these receptors are present in mollusc (77) , leech (19) , and Oreochromis sp (freshwater sh, 88) and C elegans (bluegreen algae, 50). In plants, the GluR-like receptors respond to the same antagonist as the GluRs in the CNS. The DNA sequence data also shows variable (60%-16%) homology to the glutamate receptors characterized in the mammalian system.
CONCLUSIONS AND FUTURE RESEARCH CONSIDERATIONS
In summary, GluRs have a wide and a unique distribution in peripheral tissues. These receptors are pharmacologically similar to their counterparts in the CNS, although the possibility that there are subtle distinctions such as glycosylation cannot be ignored. The presence of the GluRs in peripheral tissues may provide explanations for the autonomic disturbances (GI, salivation, cardiovascular, vomiting) that have been reported in animals dosed with potent excitotoxins such as domoic acid (38, 66, 67, 79, 80, 88, 93) . Because the EAA excitotoxicity is intimately associated with the GluRs, the toxic effects may be more generalized than initially assumed, particularly in the light that GluRs are widely present in peripheral tissues that are not protected by the blood brain barrier (7, 67) . Excitotoxicity depends on the intracellular Na and Cl ions and in the in ux of Ca 2 . It is the Ca 2 in ux that is thought to be the ultimate trigger of the toxic effects (13, 20, 21) . Based on the pattern of anatomical distribution, we suggest that these receptors may be important for the mediation of functions such as hormone regulation, heart rhythm, blood pressure, circulation and reproduction. Some of the noteworthy locations are the heart, kidney, lungs, ovary, testis and endocrine cells-suggesting they play a role on cardiorespiratory, endocrine and reproductive functions. Furthermore, they could potentially turn the tissues where they are present into target sites for the toxic effect of glutamatelike-products. Many of these are known toxins that contaminate foods and others are used as food additives or enhancers during processing. Currently, there is not enough evidence to suggest the reassessment of the regulated safety levels for these products in food since little is known about how these receptors work in each of these organs. However, it has been shown that MSG can trigger severe asthma (2) . The relatively high concentrations of the endogenous EAAs in the blood and other tissue uids (100-200 uM) suggests that peripheral GluRs may be constantly saturated and therefore would argue against a physiologica l role. The true nature of the GluRs-ligand interaction in each tissue is not known. It is possible that some ligands have more potentiating ability than others. From the toxicological point of view, it is known that various EAAs contaminants have different potencies. Some of these would have the ability to replace the weaker ligand. In addition to the potentiating ability of the compound of interest, the true local concentrations of endogenous EAAs at peripheral tissues are not known. Currently, more research will be needed to assess the extent that these receptors participate in normal functions and in the development of diseases and how they mediate the toxic effects of EAAs.
In addition to the GluRs, enkephalin (91), the dopamine (58, 63, 90, 94) , and the GABA receptors (11, 37, 76, 87) have also been described in peripheral tissues. The dopamine receptors have been localized to heart, liver, and kidney (58, 63, 90, 94) . The GABA receptors are reported in the following tissues-heart, spleen, liver, lung, small and large intestine, stomach, adrenal, testis, ovary, and urinary bladder (11) . Therefore, it appears that the circuitry that is present in the brain may also be present in the peripheral tissues. In addition, these receptors may be colocalized and interacting to produce the nal outcome.
In addition to food safety, a growing area of interest is the development of therapeutic products speci cally designed to interact with synaptic transmission of the GluRs in the CNS (16, 42, 71, 95) . It is established that a myriad of pre-and postsynaptic mechanisms exist by which iGluRs and mGluRs could modulate cell functions in the CNS. Therefore, selective agonists and antagonists could be used to modulate glutamatergic neuronal transmissions in very select areas of the CNS (70, 94) . For example, it has been suggested that NM-DAR 1 antagonists may be useful in preventing tolerance to opiate analgesia and helping control withdrawal symptoms from addictive drugs. Also, the overactivation of NMDAR 1 has been suggestive as the causal factor in chronic disease such as Huntington's, Alzheimer's, Parkinson's , HIV-related neuronal injury and amyotrophic lateral sclerosis. Therefore, antagonists of NMDAR 1 receptor function are expected to be useful in the treatment of some of these diseases. Ample research demonstrating the presence of the GluR, dopamine and GABA receptors in peripheral tissues suggests that these antagonists might have modulating functions in the peripheral organs and tissues. GluRs in peripheral tissues could also be targets for pharmacological manipulations. For example, GluRs in pancreatic islets offers a potential target for therapeutic intervention to ne-tune insulin or glucagon secretion (37, 86) . The presence of these receptors in osteoblasts and the demonstration that NMDAR activation is effective in inhibiting bone reabsorption in vitro may contribute to the development of new therapeutics for osteoporosis (14) . Of all NMDA subunits, NMDAR 1 has been shown to be the most widely distributed in the CNS (3, 20, 21, 24, 25, 36, (46) (47) (48) 51) . It is the excessive activation of this receptor that is known to cause neuronal damage. Our data and that of others also supports that the NMDAR 1 also has a wide distribution in peripheral tissues (13, (27) (28) (29) 30) . This supports a possible role in cell injury outside the CNS for this receptor.
In conclusion, it is evident that GluRs have a cell speci c distribution in neural and nonneural tissues. In these locations, they may play a pathophysiologica l role or as targeteffector sites for excitatory compounds in foods or therapeutic products. The wide distribution in plants and animals from invertebrate to primates suggests that GluRs may also represent a primitive signalling system. Further research is required to assess the signi cance and the role of the GluRs and their impact in various elds.
